A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer.

被引：0
|
作者：
Neuhaus, P
Oettle, H
Post, S
Gellert, K
Ridwelski, K
Schramm, H
Zülke, C
Fahlke, G
Langrehr, J
Riess, H
机构：
[1] Stadt Klinikum Magdeburg, Berlin, Germany
[2] Waldklinikum, Gera, Germany
[3] Otto Von Guericke Univ, Magdeburg, Germany
[4] Virchow Klinikum, Charite Campus, Berlin, Germany
[5] Univ Klinikum Regensburg, Mannheim, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1092S / 1092S
页数：1
相关论文
共 50 条
  • [1] CONKO-001: FINAL RESULTS OF THE RANDOMIZED, PROSPECTIVE, MULTICENTER PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY WITH GEMCITABINE VERSUS OBSERVATION IN PATIENTS WITH RESECTED PANCREATIC CANCER (PC)
    Riess, H.
    Neuhaus, P.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 45 - 46
  • [2] CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)
    Neuhaus, P.
    Riess, H.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase II trial of postoperative adjuvant gemcitabine and cisplatin chemotherapy followed by chemoradiation with gemcitabine in patients with resected pancreatic cancer.
    Kwon, J. H.
    Chie, E. K.
    Kim, J. H.
    Im, S.
    Oh, D.
    Kim, Y.
    Han, S.
    Lee, K.
    Jang, J.
    Kim, T.
    Kim, J. S.
    Han, H. S.
    Kim, S.
    Yoon, Y. B.
    Bang, Y.
    Ha, S. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] A randomized phase II trial of adjuvant chemotherapy with uracil / tegafur (UFT) and gemcitabine (GEM) vs. gemcitabine alone in patients with resected pancreatic cancer
    Yoshitomi, H.
    Togawa, A.
    Kimura, F.
    Shimizu, H.
    Yoshidome, H.
    Miyazaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer
    Riess, H
    Helm, A
    Niedergethmann, M
    Schmitt-Wolf, I
    Moik, M
    Hammer, C
    Zippel, K
    Weigang-Köhler, K
    Stauch, M
    Oettle, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 310S - 310S
  • [6] Timeliness of adjuvant chemotherapy in patients with resected pancreatic cancer.
    Deng, David
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Adjuvant chemotherapy with gemcitabine plus erlotinib vs. gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?-review of the open label phase III trial CONKO 005
    Wisniewski, Mathilde
    Placide, Pierre-Alain
    Granier, Sandra
    Al Shatti, Yacoub
    Al Qalaf, Shuaib
    Bouattour, Mohamed
    Lamuraglia, Michele
    Hammel, Pascal
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (05) : 399 - 402
  • [8] A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
    H Ueno
    T Kosuge
    Y Matsuyama
    J Yamamoto
    A Nakao
    S Egawa
    R Doi
    M Monden
    T Hatori
    M Tanaka
    M Shimada
    K Kanemitsu
    British Journal of Cancer, 2009, 101 : 908 - 915
  • [9] A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
    Ueno, H.
    Kosuge, T.
    Matsuyama, Y.
    Yamamoto, J.
    Nakao, A.
    Egawa, S.
    Doi, R.
    Monden, M.
    Hatori, T.
    Tanaka, M.
    Shimada, M.
    Kanemitsu, K.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 908 - 915
  • [10] JASPAC 01: Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer
    Fukutomi, Akira
    Uesaka, Katsuhiko
    Boku, Narikazu
    Kanemoto, Hideyuki
    Konishi, Masaru
    Matsumoto, Ippei
    Kaneoka, Yuji
    Shimizu, Yasuhiro
    Nakamori, Shoji
    Sakamoto, Hirohiko
    Morinaga, Soichiro
    Kainuma, Osamu
    Imai, Koji
    Sata, Naohiro
    Hishinuma, Shoichi
    Nakamura, Takayuki
    Kanai, Michio
    Hirano, Satoshi
    Yoshikawa, Yukinobu
    Ohashi, Yasuo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345